Eli Lilly And Co Stock Price, News & Analysis (NYSE:LLY)

Eli Lilly And Co trades on the New York Stock Exchange (NYSE) under the ticker symbol "LLY."

Eli Lilly And Co announced a quarterly dividend on Tuesday, June 18th. Shareholders of record on Thursday, August 15th will be paid a dividend of $0.645 per share on Tuesday, September 10th. This represents a $2.58 annualized dividend and a yield of 2.22%. The ex-dividend date is Wednesday, August 14th. View Eli Lilly And Co's Dividend History.

Eli Lilly And Co (NYSE:LLY) issued its quarterly earnings results on Tuesday, July, 30th. The company reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.45 by $0.05. The firm had revenue of $5.64 billion for the quarter, compared to the consensus estimate of $5.59 billion. Eli Lilly And Co had a return on equity of 70.86% and a net margin of 33.76%. Eli Lilly And Co's revenue for the quarter was up .9% on a year-over-year basis. During the same period in the prior year, the business earned $1.48 EPS. View Eli Lilly And Co's Earnings History.

Eli Lilly And Co is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Eli Lilly And Co.

Eli Lilly And Co will be holding an earnings conference call on Wednesday, October 23rd at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Eli Lilly And Co issued an update on its FY19 earnings guidance on Tuesday, July, 30th. The company provided earnings per share guidance of $5.67-5.77 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.66. The company issued revenue guidance of $22-22.5 billion, compared to the consensus revenue estimate of $22.18 billion.

16 brokerages have issued twelve-month price targets for Eli Lilly And Co's stock. Their forecasts range from $74.51 to $143.00. On average, they anticipate Eli Lilly And Co's share price to reach $122.5227 in the next twelve months. This suggests a possible upside of 5.5% from the stock's current price. View Analyst Price Targets for Eli Lilly And Co.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eli Lilly And Co in the last year. There are currently 7 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Eli Lilly And Co.

Media headlines about LLY stock have trended somewhat negative this week, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Eli Lilly And Co earned a media sentiment score of -1.3 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Eli Lilly And Co.

Eli Lilly And Co saw a increase in short interest during the month of August. As of August 31st, there was short interest totalling 16,682,000 shares, an increase of 45.6% from the July 31st total of 11,459,200 shares. Based on an average daily volume of 3,990,000 shares, the days-to-cover ratio is currently 4.2 days. Approximately 2.0% of the shares of the company are short sold. View Eli Lilly And Co's Current Options Chain.

Some companies that are related to Eli Lilly And Co include Johnson & Johnson (JNJ), Roche Holdings AG Basel (RHHBY), Merck & Co., Inc. (MRK), Pfizer (PFE), Novartis (NVS), Abbott Laboratories (ABT), Novo Nordisk A/S (NVO), AstraZeneca (AZN), Sanofi (SNY), AbbVie (ABBV), GlaxoSmithKline (GSK), Bristol-Myers Squibb (BMY), Commonwealth Bank of Australia (CSLLY), Celgene (CELG) and Bayer (BAYRY).

Based on aggregate information from My MarketBeat watchlists, some companies that other Eli Lilly And Co investors own include Johnson & Johnson (jnj), Pfizer (PFE), Merck & Co., Inc. (MRK), Intel (INTC), AT&T (T), General Electric (GE), Exxon Mobil (XOM), Bank of America (BAC), Verizon Communications (VZ) and Gilead Sciences (GILD).

Eli Lilly And Co's stock is owned by a number of of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (7.37%), BlackRock Inc. (6.42%), BlackRock Inc. (6.42%), Primecap Management Co. CA (4.47%), Northern Trust Corp (1.15%) and Price T Rowe Associates Inc. MD (0.89%). Company insiders that own Eli Lilly And Co stock include Aarti S Shah, Alfonso G Zulueta, Christi Shaw, Daniel Skovronsky, Donald A Zakrowski, Eli & Co Lilly, Enrique A Conterno, Jackson P Tai, Jeffrey N Simmons, Joshua L Smiley, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill, Stephen F Fry and Susan Mahony. View Institutional Ownership Trends for Eli Lilly And Co.

LLY stock was sold by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, Janus Henderson Group PLC, Jennison Associates LLC, Jennison Associates LLC, Schroder Investment Management Group, Morgan Stanley, Nomura Holdings Inc. and Nomura Holdings Inc.. Company insiders that have sold Eli Lilly And Co company stock in the last year include Aarti S Shah, Alfonso G Zulueta, Christi Shaw, Donald A Zakrowski, Eli & Co Lilly, Enrique A Conterno, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill and Stephen F Fry. View Insider Buying and Selling for Eli Lilly And Co.

LLY stock was bought by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Renaissance Technologies LLC, Grantham Mayo Van Otterloo & Co. LLC, AQR Capital Management LLC, BlackRock Inc., BlackRock Inc., Thoroughbred Financial Services LLC and Amundi Pioneer Asset Management Inc.. Company insiders that have bought Eli Lilly And Co stock in the last two years include Daniel Skovronsky, Jackson P Tai and Joshua L Smiley. View Insider Buying and Selling for Eli Lilly And Co.

Shares of LLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LLY stock can currently be purchased for approximately $116.16.

Eli Lilly And Co has a market capitalization of $112.14 billion and generates $24.56 billion in revenue each year. The company earns $3.23 billion in net income (profit) each year or $5.55 on an earnings per share basis. Eli Lilly And Co employs 38,680 workers across the globe.View Additional Information About Eli Lilly And Co.

The official website for Eli Lilly And Co is http://www.lilly.com/.

Eli Lilly And Co's mailing address is LILLY CORPORATE CENTER, INDIANAPOLIS IN, 46285. The company can be reached via phone at 317-276-2000 or via email at [email protected]